Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05813067 · ClinicalTrials.gov registry record · NA
Herbal Nutraceutical Supplementation on Vasomotor Symptoms in Menopausal Women
A NA study, sponsored by Bonafide Health.
- Completed
- Registry status
- NA
- Development phase
- 74
- Enrollment target
NCT05813067: Completed NA study, sponsored by Bonafide Health.
NCT05813067 is a NA study that has completed, run by Bonafide Health. The registered enrollment target is 74 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05813067, a NA study, has completed, sponsored by Bonafide Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 74 participants
- Enrollment target
Study Summary
The role of nutrition is recognized as a vital component to healthy aging throughout menopause. The goal of this study is to evaluate a dietary supplement for its safety and effects on vasomotor symptoms in menopausal women.
Primary Outcome
Change from baseline for the number and severity of hot flashes measured by HFRDIS scores. The HFRDIS has a scoring range of 0-100, with higher values indicating worse symptoms.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT JDS-HF 3.0
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2022-12-27 |
| Est. Completion | 2024-04-23 |
| Phase | NA |
What the finished NCT05813067 record still lists
NCT05813067 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05813067 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05813067 about?
NCT05813067 is a clinical study titled "Herbal Nutraceutical Supplementation on Vasomotor Symptoms in Menopausal Women". The role of nutrition is recognized as a vital component to healthy aging throughout menopause. The goal of this study is to evaluate a dietary supplement for its safety and effects on vasomotor symptoms in menopausal women.
What is the current status of trial NCT05813067?
This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2022-12-27. Estimated completion is 2024-04-23.
What interventions are being tested in trial NCT05813067?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), JDS-HF 3.0 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05813067?
This trial is sponsored by Bonafide Health, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05813067's enrollment target sits among peer trials
74 1082nd of 2000 higher than 912 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422731 · 74 participants · Early Phase 1
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- NCT03804853 · 74 participants · NA
Rehabilitation Following Reverse Total Shoulder Arthroplasty
- NCT04065776 · 74 participants · NA
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
- NCT04771156 · 74 participants · Phase 4
Ketorolac in Palatoplasty
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI